- Home
- RXST vs SRZN Comparison
RXST vs SRZN Comparison
Compare RXST & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXST | SRZN |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.2M | 271.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RXST | SRZN |
|---|---|---|
| Price | $5.22 | $20.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $9.78 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 1.4M | 176.5K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $134,479,000.00 | N/A |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | $10.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.48 | $8.70 |
| 52 Week High | $13.22 | $35.00 |
Technical Indicators
Market Signals| Indicator | RXST | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 34.60 |
| Support Level | $4.60 | $16.75 |
| Resistance Level | $5.92 | $21.40 |
| Average True Range (ATR) | 0.43 | 1.78 |
| MACD | 0.02 | -0.16 |
| Stochastic Oscillator | 39.11 | 6.36 |
Price Performance
Historical ComparisonAbout RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).